(NYSE: DGX) Quest Diagnostics's forecast annual revenue growth rate of -11.92% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 72.18%.
Quest Diagnostics's revenue in 2023 is $10,294,000,000.On average, 6 Wall Street analysts forecast DGX's revenue for 2023 to be $1,032,573,693,660, with the lowest DGX revenue forecast at $1,018,142,557,293, and the highest DGX revenue forecast at $1,075,553,228,904.
In 2024, DGX is forecast to generate $1,041,746,076,284 in revenue, with the lowest revenue forecast at $1,022,282,480,570 and the highest revenue forecast at $1,059,739,954,250.